Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension

Canadian Journal of Cardiology

Volumn 30, Issue 2, 2014, Pages 188-194

  Gregori, Mario ^a   Tocci, Giuliano ^a,b   Giammarioli, Benedetta ^a   Befani, Alberto ^a   Ciavarella, Giuseppino Massimo ^a   Ferrucci, Andrea ^a   Paneni, Francesco ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; RENIN; SODIUM;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; FEMALE; HEART PERFORMANCE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PLASMA RENIN ACTIVITY; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; SUPINE POSITION; TISSUE DOPPLER IMAGING; TRANSTHORACIC ECHOCARDIOGRAPHY; URINARY EXCRETION;

ADULT; ALDOSTERONE; BLOOD PRESSURE; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; RENIN; RENIN-ANGIOTENSIN SYSTEM; VENTRICULAR DYSFUNCTION, RIGHT; VENTRICULAR FUNCTION, RIGHT;

EID: 84892967960     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2013.11.009     Document Type: Article

References (29)

1. Morrissey R.P., Czer L., Shah P.K. Chronic heart failure: current evidence, challenges to therapy, and future directions. Am J Cardiovasc Drugs 2011, 11:153-171.
2. Sciarretta S., Paneni F., Palano F., et al. Role of the renin angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci (Lond) 2009, 116:467-477.
3. Schmidt B.M., Schmieder R.E. Aldosterone-induced cardiac damage: focus on blood pressure independent effects. Am J Hypertens 2003, 16:80-86.
4. Gregori M., Tocci G., Marra A., et al. Inadequate RAAS suppression is associated with excessive left ventricular mass and systo-diastolic dysfunction. Clin Res Cardiol 2013, 102:725-733.
5. Iglesias-Garriz I., Olalla-Gómez C., Garrote C., et al. Contribution of right ventricular dysfunction to heart failure mortality: a meta-analysis. Rev Cardiovasc Med 2012, 13:e62-e69.
6. Valsangiacomo Buechel E.R., Mertens L.L. Imaging the right heart: the use of integrated multimodality imaging. Eur Heart J 2012, 33:949-960.
7. Sade L.E., Gülmez O., Ozyer U., et al. Tissue Doppler study of the right ventricle with a multisegmental approach: comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2009 Apr, 22(4):361-368.
8. Paneni F., Gregori M., Ciavarella G.M., et al. Right ventricular dysfunction in patients with end-stage renal disease. Am J Nephrol 2010, 32:432-438.
9. Paneni F., Gregori M., Pignatelli G., et al. Pathophysiology of biventricular dysfunction during hemodialysis: emerging concepts. Int J Cardiol 2012, 155:478-479.
10. Paneni F., Gregori M., Ciavarella G.M., et al. Relation between right and left ventricular function in patients undergoing chronic dialysis. J Cardiovasc Med (Hagerstown) 2013, 14:289-295.
11. Mancia G., Fagard R., Narkiewicz K., et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2013 ESH ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2013, 31:1281-1357.
12. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
13. Rudski L.J., Lai W.W., Afilalo J., et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010, 23:685-713.
14. Rajagopalan N., Simon M.A., Shah H., et al. Utility of right ventricular tissue Doppler imaging: correlation with right heart catheterization. Echocardiography 2008, 25:706-711.
15. Paneni F., Gregori M., Tocci G., et al. Do diabetes, metabolic syndrome or their association equally affect biventricular functionα A tissue Doppler study. Hypertens Res 2013, 36:36-42.
16. Volpe M., Unger T. Plasma renin and cardiovascular risk: what is the evidence for an associationα. Cardiology 2013, 125:50-59.
17. Gregori M., Tocci G., Befani A., et al. Synergic effect of high renin and aldosterone levels on inappropriate left ventricular mass and systolic function: a tissue Doppler study. Int J Cardiol 2013, 168:4934-4936.
18. Guglin M., Verma S. Right side of heart failure. Heart Fail Rev 2012, 17:511-527.
19. Sciarretta S., Palano F., Tocci G., et al. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med 2011, 171:384-394.
20. Schunkert H., Hense H.W., Muscholl M., et al. Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart 1997, 77:24-31.
21. Pechlivanidis G., Mantziari L., Giannakoulas G., et al. Effects of renin-angiotensin system inhibition on right ventricular function in patients with mild essential hypertension. J Renin Angiotensin Aldosterone Syst 2011, 12:358-364.
22. Lindqvist P., Calcutteea A., Henein M. Echocardiography in the assessment of right heart function. Eur J Echocardiogr 2008, 9:225-234.
23. Paneni F., Gregori M., Ciavarella G.M., et al. Impact of dialysis modality on the appropriateness of left ventricular mass in patients with end-stage renal disease. Int J Cardiol 2011, 149:250-252.
24. Paneni F., Gregori M., Marra A., et al. Preclinical effects of healthy obesity on inappropriate left ventricular mass and systolic function. Int J Cardiol 2013, 167:3047-3049.
25. Silvestre J.S., Robert V., Heymes C., et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998, 273:4883-4891.
26. Robert V., Heymes C., Silvestre J.S., et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt induced fibrosis. Hypertension 1999, 33:981-986.
27. Gong S.Z., Liu P.Q., Lu W., et al. Effect of aldosterone on the secretion of endothelin by ventricular fibroblasts. Sheng Li Xue Bao 2001, 53:23-26.
28. Campbell S.E., Janicki J.S., Weber K.T. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol 1995, 27:1545-1560.
29. Freel E.M., Mark P.B., Weir R.A., et al. Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study. Circ Cardiovasc Imaging 2012, 5:740-747.